Description

[3-Cyclopropyl-4-(Methoxycarbonyl)-6-Methyl-1H-Pyrazolo[3,4-B]Pyridin-1-Yl]Acetic Acid is a high-purity, advanced pharmaceutical intermediate with a complex heterocyclic structure. This compound is valued for its role as a critical building block in the synthesis of novel active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring targeted molecular scaffolds. It is essential for research institutions and pharmaceutical manufacturers engaged in the development of new drug candidates, especially within oncology and anti-inflammatory research pipelines.

Application

• Pharmaceutical Intermediate: A key precursor in the multi-step synthesis of complex drug molecules and investigational new drugs.
• API Development: Serves as a core structural component for building novel Active Pharmaceutical Ingredients with specific biological activity.
• Medicinal Chemistry Research: Used in research laboratories for structure-activity relationship (SAR) studies and lead optimization.
• Contract Manufacturing: Supplied to CDMOs (Contract Development and Manufacturing Organizations) for cGMP production of clinical trial materials.
• Biochemical Reagent: May be utilized as a specialized reagent in biochemical assays and proteomics research.
• Chemical Reference Standard: Suitable for use as a high-purity analytical standard for quality control and method development.

Basic Information

Product Name	[3-Cyclopropyl-4-(Methoxycarbonyl)-6-Methyl-1H-Pyrazolo[3,4-B]Pyridin-1-Yl]Acetic Acid
CAS No.	1018141-95-1
Molecular Formula	C15H15N3O4
Molecular Weight	301.30 g/mol
Synonyms	1H-Pyrazolo[3,4-b]pyridine-1-acetic acid, 3-cyclopropyl-4-(methoxycarbonyl)-6-methyl-; (3-Cyclopropyl-4-methoxycarbonyl-6-methyl-1H-pyrazolo[3,4-b]pyridin-1-yl)acetic acid; Pyrazolopyridine acetic acid derivative; CAS 1018141-95-1; 3-Cyclopropyl-4-carbomethoxy-6-methyl-1H-pyrazolo[3,4-b]pyridin-1-ylacetic Acid
EINECS	Contact for details

Quality Control

Our production of [3-Cyclopropyl-4-(Methoxycarbonyl)-6-Methyl-1H-Pyrazolo[3,4-B]Pyridin-1-Yl]Acetic Acid adheres to stringent quality management protocols to ensure batch-to-batch consistency and high purity suitable for pharmaceutical research. All materials are characterized by advanced analytical techniques including HPLC, NMR, and mass spectrometry. A comprehensive Certificate of Analysis (COA) detailing purity, identity, and impurity profiles is provided with each shipment to support your regulatory and R&D documentation needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed after opening to prevent degradation from atmospheric moisture. For long-term storage, consider using desiccants.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (HPLC)	Conforms to reference standard
Identification (IR)	Conforms to structure
Assay (HPLC)	≥ 98.0%
Purity (HPLC, Area %)	≥ 98.5%
Single Maximum Impurity	≤ 0.5%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.